Exalenz Bioscience Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for the assessment and monitoring of functional disorders. Its flagship product, BreathID Hp is a US FDA approved and European CE marked urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults as well as pediatric and tests patients of 3 to 17 years of age. It offers BreathID Gastro used for the diagnosis of liver and GI disorders. Exalenz also offers BreathID 13C-methacetin breath test, a non-invasive point of care tool that measures the microsomal function of the liver. Exalenz is headquartered in Modiin, Israel.
Note: Some sections may be missing if data is unavailable for the company.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Our summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for the assessment and monitoring of functional disorders. Its flagship product, BreathID Hp is a US FDA approved and European CE marked urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults as well as pediatric and tests patients of 3 to 17 years of age. It offers BreathID Gastro used for the diagnosis of liver and GI disorders. Exalenz also offers BreathID 13C-methacetin breath test, a non-invasive point of care tool that measures the microsomal function of the liver. Exalenz is headquartered in Modiin, Israel.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company’s Lifesciences Financial Deals and Alliances
Section 4 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Serim Research Corporation
- Meridian Bioscience Inc
- MedMira Inc
- Kibion AB
- Becton Dickinson and Co